In English
NIDA

NIDA Notes Articles: Clinical Trials Network

NIDA Notes Category Graphic

Low-Cost Incentives Improve Outcomes in Stimulant Abuse Treatment

octubre del 2006
Reports on a study investigating the use of incentives in the form of prizes to motivate outpatients to stay in behavioral therapy and remain drug free.

NIDA Notes Category Graphic

Addiction and Co-Occurring Mental Disorders

febrero del 2007

Presents an overview of the research underway to investigate medication and behavioral therapies for co-occurring disorders.

NIDA Notes Category Graphic

Incentives Reduce Stimulant Abuse During Methadone Maintenance

abril del 2007

Summarizes a study on the use of incentives to encourage abstinence among methadone maintenance patients in outpatient programs.

NIDA Notes Category Graphic

Dr. Phil Skolnick Now Leads NIDA's Medications Development Efforts

abril del 2010
Announces the appointment of Dr. Phil Skolnick as NIDA’s director of the Division of Pharmacotherapies and Medical Consequences of Drug Abuse.

NIDA Notes Category Graphic

Young Opioid Abusers Benefit From Extended Buprenorphine-Naloxone Treatment

abril del 2010
Reports on a study investigating the benefits of extended opioid maintenance therapy that included drug counseling and 12 weeks of therapy with buprenorphine and naloxone.

NIDA Notes Category Graphic

Dr. Kathleen T. Brady Recognized

octubre del 2010
Recognizes the 2010 Distinguished University Professor awardee, Dr. Kathleen T. Brady, who studies co-occurring substance abuse and mental health disorders and their treatment.

NIDA Notes Category Graphic

Intensive Interventions Reduce Risky Sexual Behaviors

julio del 2011
Discusses research that compares multiple sessions of motivational and behavioral training with that of a single intervention among male and female substance abusers to reduce high-risk sexual behaviors.

NIDA Notes Category Graphic

NIDA Announces Avant-Garde Medication Development Awards

Marzo del 2012
Dr. Thomas Kosten of Baylor College of Medicine and Dr. Peter Burkhard of the University of Connecticut are the recipients of NIDA’s 2011 Avant-Garde Awards for Innovative Medication Development Research. Dr. Kosten is developing a vaccine against methamphetamine abuse and Dr. Burkhard is developing a vaccine to counter nicotine addiction.

NIDA Notes Category Graphic

Alleviation of Posttraumatic Stress Disorder May Improve Addiction Treatment

abril del 2012

Women with posttraumatic stress disorder (PTSD) who abused drugs responded better to substance abuse treatment after their PTSD symptoms improved, according to a recent study, which also found that reductions in substance abuse did not ease PTSD severity

NIDA Notes Category Graphic

Women and Sex/Gender Differences Research Program

abril del 2012
NIDA’s Women and Sex/Gender Differences Research Program focuses on gender-specific addiction risk factors and treatment needs.

Páginas

NIDA Notes

Tags

Drug Topics

Drugs of Abuse

Population Groups

Related Topics

Toma el reto nacional sobre el coeficiente intelectual (CI) sobre las drogas